ampelopsin has been researched along with Acute Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jia, R; Ma, J; Meng, W; Wang, N | 1 |
Li, H; Miu, J; Sun, X; Xiao, P; Xu, L; Yu, F | 1 |
2 other study(ies) available for ampelopsin and Acute Disease
Article | Year |
---|---|
Dihydromyricetin inhibits caerulin-induced TRAF3-p38 signaling activation and acute pancreatitis response.
Topics: Acute Disease; Animals; Cell Death; Cell Survival; Cells, Cultured; Ceruletide; Cytokines; Flavonols; Macrophages; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Signal Transduction; TNF Receptor-Associated Factor 3 | 2018 |
Dihydromyricetin ameliorates memory impairment induced by acute sleep deprivation.
Topics: Acute Disease; Animals; Flavonols; Maze Learning; Memory Disorders; Mice; Neuronal Plasticity; Oxidative Stress; Sleep Deprivation | 2019 |